Analystreport

Syros Pharmaceuticals Inc (NASDAQ: SYRS) was given a new $28.00 price target on by analysts at Oppenheimer Holdings Inc.. They now have a "buy" rating on the stock.

Syros Pharmaceuticals, Inc.  (SYRS) 
Last syros pharmaceuticals, inc. earnings: 3/5 06:57 am Check Earnings Report
US:NASDAQ Investor Relations: ir.syros.com